Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Medicine, Lanzhou University, 222 Tian Shui South Road, Lanzhou 730000, PR China.
Biochem Pharmacol. 2011 Mar 1;81(5):661-8. doi: 10.1016/j.bcp.2010.12.007. Epub 2010 Dec 17.
Human hemokinin-1 (hHK-1) is a substance P-like tachykinin peptide preferentially expressed in non-neuronal tissues. It is involved in multiple physiological functions such as inflammation, hematopoietic cells development and vasodilatation via the interaction with tachykinin receptor neurokinin-1 (NK1). To further understand the intracellular signal transduction mechanism under such functional multiplicity, current study was focused on the differential activation of Gs and Gq pathways by hHK-1 and its C-terminal fragments, which is termed as functional selectivity. We demonstrated these hHK-1 and related peptide fragments can independently activate Gs and Gq pathways, showing a relative bias toward Gq over Gs pathway. The T1, K3 and Q6 of hHK-1 might play roles in the activation of adenylate cyclase mediated by Gs, while having negligible effect on Gq mediated intracellular calcium release. The stepwise truncation of N-terminal amino acid of hHK-1 caused gradual decrease in ERK1/2 phosphorylation level and NF-κB activity. However, it had little influence on the induction of NK1 receptor desensitization and internalization. Taken together these data support that hHK-1 and its C-terminal fragments are human NK1 receptor agonists with different functional selectivity properties and that such functional selectivity leads to differential activation of downstream signaling and receptor trafficking.
人源速激肽-1(hHK-1)是一种 P 物质样速激肽,在非神经元组织中优先表达。它通过与速激肽受体神经激肽-1(NK1)相互作用,参与多种生理功能,如炎症、造血细胞发育和血管扩张。为了进一步了解这种多功能性下的细胞内信号转导机制,本研究集中于 hHK-1 及其 C 末端片段对 Gs 和 Gq 途径的差异激活,这被称为功能选择性。我们证明这些 hHK-1 和相关肽片段可以独立激活 Gs 和 Gq 途径,表现出对 Gq 途径的相对偏向性,而对 Gs 途径的激活作用较小。hHK-1 的 T1、K3 和 Q6 可能在 Gs 介导的环腺苷酸酶激活中发挥作用,而对 Gq 介导的细胞内钙释放几乎没有影响。hHK-1 的 N 端氨基酸的逐步截断导致 ERK1/2 磷酸化水平和 NF-κB 活性逐渐降低。然而,它对 NK1 受体脱敏和内化的诱导几乎没有影响。综上所述,这些数据支持 hHK-1 和其 C 末端片段是人类 NK1 受体激动剂,具有不同的功能选择性特性,这种功能选择性导致下游信号转导和受体运输的差异激活。